Decompressive Craniectomy for Stroke: Who, When, and How - 22/04/22
, J. Marc Simard, MD, PhD a, b, cRiassunto |
Malignant cerebral edema after large hemispheric infarct is a highly morbid condition, and major, randomized trials over the last 2 decades have affirmed the beneficial effect of surgical intervention in the form of decompressive craniectomy. Early (<48 hours) decompressive craniectomy increases good functional outcomes (mRS 0–3) and reduces mortality. Additionally, trials have found the benefit of surgery to persist in those patients more than 60 years, though the apparent benefit is of lesser magnitude. A summary table of the major randomized trials of decompressive craniectomy is included. A detailed description and figures of the decompressive craniectomy procedure is included. The complications of decompressive craniectomy are also discussed, and recent literature on promising alternatives, both surgical and medical, is reviewed.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Decompressive craniectomy, Large hemispheric infarct, Malignant cerebral edema, Ischemic stroke, Glibenclamide
Mappa
| Funding: This article was not funded. JMS is supported by grants from the Department of Veterans Affairs (I01BX002889), the Department of Defense (SCI170199), the National Heart, Lung and Blood Institute (R01HL082517), and the NINDS (R01NS060801; R01NS102589; R01NS105633).50 |
Vol 40 - N° 2
P. 321-336 - maggio 2022 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
